Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Australia To Fund Bionic Eye Research For Lost, Impaired Vision

This article was originally published in PharmAsia News

Executive Summary

Australia said it would contribute U.S.$35 million toward research into development of a prosthesis to restore or enhance vision in people with impairments. Prime Minister Kevin Rudd said the commitment to developing a "bionic eye" was important because millions of Australians have impaired vision and the technology gained might be adapted to other areas of need. The prosthetic eye envisioned would be able to restore lost vision or amplify existing vision. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071423

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel